Market Cap : 388.98 M | Enterprise Value : 361.7 M | PE Ratio : 15.29 | PB Ratio : 7.72 |
---|
NAS:CODX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CODX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net margin is calculated as Net Income divided by its Revenue. Co-Diagnostics's Net Income for the three months ended in Sep. 2020 was $15.73 Mil. Co-Diagnostics's Revenue for the three months ended in Sep. 2020 was $21.82 Mil. Therefore, Co-Diagnostics's net margin for the quarter that ended in Sep. 2020 was 72.10%.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Co-Diagnostics's Net Margin % falls into.
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Co-Diagnostics's Net Margin for the fiscal year that ended in Dec. 2019 is calculated as
Net Margin | = | Net Income (A: Dec. 2019 ) | / | Revenue (A: Dec. 2019 ) |
= | -6.196 | / | 0.215 | |
= | -2,881.86 % |
Co-Diagnostics's Net Margin for the quarter that ended in Sep. 2020 is calculated as
Net Margin | = | Net Income (Q: Sep. 2020 ) | / | Revenue (Q: Sep. 2020 ) |
= | 15.732 | / | 21.819 | |
= | 72.10 % |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
No Headline